Drug intelligence / Profile preview

[89Zr]Zr-Df-SA

Development stage
Preclinical
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

[89Zr]Zr-Df-SA is a radiolabeled protein conjugate designed for use in positron emission tomography (PET) imaging. It consists of the positron-emitting radioisotope zirconium-89 (89Zr) chelated by deferoxamine (Df) and covalently linked to streptavidin (SA). This complex serves as a modular diagnostic platform that leverages the exceptionally high affinity between streptavidin and biotin to attach the radioactive tracer to biotinylated targeting moieties, such as aptamers or antibodies. In preclinical research, it has been utilized to label an anti-PSMA dimeric aptamer (BioDAC) for the detection of prostate cancer. A notable characteristic of this conjugate is its high renal retention, attributed to the streptavidin component, which currently limits its clinical translation and necessitates further structural optimization to reduce off-target radioactivity.

Other names
89Zr-Df-streptavidin89Zr-labeled deferoxamine-streptavidin
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on [89Zr]Zr-Df-SA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [89Zr]Zr-Df-SA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call